With €470M first close, Forbion’s new growth fund one of Europe’s largest

Forbion Capital’s latest growth fund may offer much-needed support to European biotechs as the public markets continue to offer little opportunity in the near-term.

On Thursday, the firm announced the first close of Forbion Growth Opportunities Fund II at €470 million ($504.9 million), already above the fund’s €450 million target. The new fund comes just two years after Forbion closed its first growth fund at a hard cap of €360 million...